The Animal Protective League (APL) presents their annual APL Chili Supper and Paw Paw Patch Bazaar this Sunday, October ...
Adani Power posted revenue from operations at Rs 13,338.88 crore, up 2.7 per cent as against Rs 12,990.58 crore during the ...
This week, the Cleveland APL is showcasing a 2-year-old dog named Ghostie. (Truly in the Halloween spirit!) ...
The County Animal Protective League is having a $25 adoption special for dogs and cats until Thursday. The discounts only apply to adult pet adoption. Kittens are $75, and puppies are $180. APL ...
The Maryland Daily Record selected APL Director Ralph Semmel as a 2024 Icon Honors recipient. Honorees are recognized for ...
After a solid FY24, where the company’s earnings grew by 11 percent year-on-year despite declining sales volumes ...
"Project CARE is our Community Animal Retention Effort. That's what CARE stands for," said Sharon Harvey, President and CEO of the Cleveland APL. She describes it as a "boots on the ground grassroots ...
Researchers at APL are working on applications to increase our understanding of how space weather impacts critical national ...
格隆汇10月24日丨亚虹医药(688176.SH)公布,收到美国食品药品监督管理局(简称“FDA”)关于同意开展公司自主研发的APL-2302用于治疗晚期实体瘤临床试验的函告。APL-2302是公司自主研发的一种泛素特异性蛋白酶1(USP1)抑制剂, ...
It's capable of delivering majestic phenomena like the auroras near Earth's poles, but it can also have more alarming ...
【亚虹医药:APL-2302临床试验获FDA批准】 亚虹医药公告,公司自主研发的APL-2302用于治疗晚期实体瘤的临床试验申请已获得美国FDA批准。APL-2302是一种USP1抑制剂,通过“合成致死”机制发挥抗肿瘤作用,临床前研究显示其在肿瘤抑制方面具有良好活性。
亚虹医药公告,近日,收到美国食品药品监督管理局(简称“FDA”)关于同意开展公司自主研发的APL-2302用于治疗晚期实体瘤临床试验的函告。APL-2302临床试验申请获FDA批准后,公司将尽快向中国国家药品监督管理局(NMPA)药品审评中心(CDE)递交新药临床试验申请(IND),积极推动该项临床试验在全球范围内的开展。本次APL ...